Table 2.
Study | Interventions | n(Group) = Sample Size |
Mean within-Group Difference from Baseline | Relative Risk Reduction | TR vs. OB (p Values) |
---|---|---|---|---|---|
Allen et al. [18] | Pain WOMAC-Month 4 | Pain WOMAC-Month 4 | 0.20 | ||
TR | n(TR) = 112 | TR: 1.59 | RRR TR: 7.9% | ||
OB | n(OB) = 129 | OB: 1.11 | RRR OB: 5.5% | ||
CL | n(CL) = 63 | CL: 0.66 | RRR CL: 3.3% | ||
Pain WOMAC-Month 12 | Pain WOMAC-Month 12 | 0.22 | |||
TR: 1.15 | RRR TR: 5.7% | ||||
OB: 0.7 | RRR OB: 3.5% | ||||
CL: 0.64 | RRR CL: 3.2% | ||||
Function WOMAC-Month 4 | Function WOMAC-Month 4 | 0.33 | |||
TR: 3.74 | RRR TR: 5.5% | ||||
OB: 4.77 | RRR OB: 7.0% | ||||
CL: 2.3 | RRR CL: 3.4% | ||||
Function WOMAC-Month 12 | Function WOMAC-Month12 | 0.93 | |||
TR: 3.4 | RRR TR: 5.0% | ||||
OB: 3.3 | RRR OB: 4.8% | ||||
CL: 1.51 | RRR CL: 2.2% | ||||
Total WOMAC-Month 4 | Total WOMAC-Month 4 | 0.65 | |||
TR: 6.06 | RRR TR: 6.3% | ||||
OB: 6.73 | RRR OB: 7.0% | ||||
CL: 3.37 | RRR CL: 3.5% | ||||
Total WOMAC-Month 12 | Total WOMAC-Month 12 | 0.51 | |||
TR: 5.46 | RRR TR: 5.6% | ||||
OB: 4.42 CL: 2.83 |
RRR OB: 4.6% RRR CL: 2.9% |
||||
Azma et al. [19] | Total WOMAC-Week 6 | Total WOMAC-Week 6 | 0.66 | ||
TR | n(TR) = 27 | TR: 31.79 | RRR TR: 31.8% | ||
OB | n(OB) = 27 | OB: 31.54 | RRR OB: 31.5% | ||
Bennell et al. [20] | Pain WOMAC-Month 6 | Pain WOMAC-Month 6 | >0.05 | ||
Rehabilitation + TR | n(TR) = 84 | TR: 3.5 | RRR TR: 17.5% | ||
OB | n(OB) = 84 | OB: 2.9 | RRR OB: 14.5% | ||
Function WOMAC-Month 6 | Function WOMAC-Month 6 | >0.05 | |||
TR: 11.8 | RRR TR: 17.3% | ||||
OB: 11.4 | RRR OB: 16.8% |